- Big Shareholders Ask Goldman to Cut Bonuses: Report
- GE, Vivendi $1 Billion Apart over NBCU Stake: Report
- In Wall Street's Back Yard, Unemployment Rises
- Dell Shares Smacked as Earnings, Sales Miss Forecasts
- US Senators Want Probe into Alleged Yuan 'Manipulation'
- Oprah to Leave Syndication in 2011
- The Art of the High-End Comic Strip
- Heidi Klum Wows Crowd at Victoria's Secret Show
- House Panel OKs Plan to Open Fed Policy to Audits
- Drugs, Booze and Vegas
- Expect a 5-10% Market Pullback: Stock Picker
- Dell Has Some Explaining to Do
- 3 Stock Picks for This Volatile Environment: Portfolio Manager
- Tamminen: California Is At It Again
- Iverson Wasn't A Popular "Answer"
- Nov. 19: Unusual Volume Leaders
- 3 Financial Stocks May Lead Final Rally: Market Researcher
- My Top 10 Marketing Ideas For Winless Nets
- AirAsia swings back to $38.4 million profit in Q3
- Volkswagen board moves closer to Porsche merger
- Liberace, Cruise, Palin among Winfrey's highlights
- Malaysia's economy shrinks 1.2 percent in Q3
- Serbia launches tender for landline phone operator
- San Francisco's health care a model during debate
- Free clinics tied to health care debate
- China's CNPC agrees to expand Sudan refinery
- S. Korean minister nixes new US trade negotiations
NATICK, Mass - Dr. Donald Baim, a renowned cardiologist and medical device executive, died Friday following surgery to treat a form of cancer, his family said in a statement. He was 60.
Baim had undergone recent surgery to remove diseased tissue caused by adrenal cancer, a rare form of the disease that attacks the adrenal glands.
Baim, a former Harvard medical school professor, most recently served as chief medical officer for Boston Scientific Corp., a leading manufacturer of pacemakers, defibrillators and other implants. He joined the company in 2006.
Boston Scientific Chief Executive Ray Elliot called Baim, "a pioneer in the development of interventional cardiology."
"The many contributions he made to science, medicine and medical technology will serve as a proud and enduring legacy," Elliot said in a statement to employees.
A company spokesman declined to comment on who would take over the medical officer position.
Baim joined Harvard Medical School in 1981 and established the interventional cardiology program at Beth Israel medical center, a teaching hospital for Harvard students. The program specialized in training surgeons to use new medical devices, including stents. The mesh-metal tubes are used to prop open arteries after they have been cleared of fatty plaque.
Baim edited the standard medical textbook for using the devices.
In 2000, Baim moved to Brigham and Women's Hospital, also in Boston.
Baim received his medical degree from Yale University and completed training in cardiology and internal medicine at Stanford University.
Memorial services are set for Monday in Canton, Mass.
- Alternative energy's hot spot is making a comeback after some dark days in the past year.
- Athena Health is offering an electronic records and billing system to boost cash flow and simplify payments.
- The world’s two largest carbon emitters — the US and China — may have put a nail in the coffin of a global carbon reduction agreement.
- Every investor knows the connection between stocks and the dollar. But is there any method to the market's madness?
- NBA’s New Jersey Nets have yet to win a game this year. How can they get people to see them play?
- CNBC contributor David Pogue looks at a wireless speaker system designed to play music throughout your home.









